POC development in a post-COVID-19 world
Hydrix recently undertook a market research initiative focusing on the in-vitro diagnostics/point-of-care (IVD/POC) market, engaging with key stakeholders in the…
Hydrix, a company with 20-year track record of medical device development, recently undertook a market research initiative focusing on the in-vitro diagnostics/point-of-care (IVD/POC) market, engaging with key stakeholders in the US and EU. Our primary objective was to gain insights into market characteristics in the aftermath of the COVID-19 pandemic, identifying trends and learning of the challenges and opportunities that lay ahead.
Arrange a meeting with our team or drop by our booth to learn more about these insights and how they inform our approach to solving your most immediate Point of Care instrument development challenges.
